For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

A thyroglobulin antibody (TgAb) test looks for certain antibodies that attack the thyroid. The presence of TbAb in high levels may indicate that someone has an autoimmune condition. To conduct a ...

Laboratory test results are shown in Table 1. Nucleic acid testing for SARS-CoV-2 and influenza types A and B was negative. An antibody test for Lyme disease was nonreactive. An electrocardiogram ...

Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a condition of the nervous system that can be managed with lifestyle modifications or medications, depending on your individual needs.

Uric acid is a waste product found in urine. If your body makes too much or doesn't eliminate enough of it, uric acid levels can become too high—a condition known as hyperuricemia. High uric acid ...

The research team has developed a novel solution by designing peptides—short strings of amino acids—to bind with ... with a thin peptide coating that improves solubility, enhances stability ...

The peptide, which is a short chain of amino acids, has shown effectiveness in experiments involving various coronavirus strains attempting to infect human cell lines and hamsters. Researchers ...

AUSTIN, Texas--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd ... optimized its GLP-1 alternatives for compatibility with nucleic acid-based expression systems in collaboration with Aldevron ...

ImmunoPrecise Antibodies Ltd. (IPA ... IPA applied rational genetic engineering to enhance peptide longevity and performance in early-stage studies. Additionally, IPA has optimized its GLP-1 ...